Clinical Trial Update: Phase II Trial of Stereotactic Radiosurgery Boost Following Surgical Resection for Brain Metastases [Phase 2]

View source ↗

Summary

Phase II trial evaluating stereotactic radiosurgery boost after surgical resection for brain metastases has completed, with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Brain Metastases

Snippet

Sponsor: Memorial Sloan Kettering Cancer Center | Conditions: Brain Metastasis, Bladder Cancer | Phase 2 | Status: COMPLETED | Results posted: 2016-02-22